Ovarian steroid hormones differentially regulate thrombospondin-1 expression in cultured endometrial stromal cells: implications for endometriosis

Fertility and Sterility

Volumn 93, Issue 1, 2010, Pages 328-331

  Tan, Xian Jie ^a   Lang, Jing He ^a   Zheng, Wei Ming ^b   Leng, Jin Hua ^a   Zhu, Lan ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

angiogenesis; endometriosis; Estrogen; progesterone; thrombospondin 1

Indexed keywords

ESTRADIOL; GESTAGEN; MESSENGER RNA; PROGESTERONE; THROMBOSPONDIN 1;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; THERAPY EFFECT; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CELLS, CULTURED; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; OVARY; PROGESTERONE; RNA, MESSENGER; STROMAL CELLS; THROMBOSPONDIN 1; TIME FACTORS;

EID: 72749122493     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.06.060     Document Type: Article

References (27)

1. Good D.J., Polverini P.J., Rastinejad F., Le Beau M.M., Lemons R.S., Frazier W.A., et al. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 87 (1990) 6624-6628
2. Ren B., Yee K.O., Lawler J., and Khosravi-Far R. Regulation of tumor angiogenesis by thrombospondin-1. Biochim Biophys Acta 1765 (2006) 178-188
3. Roberts D.D., Isenberg J.S., Ridnour L.A., and Wink D.A. Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis. Clin Cancer Res 13 (2007) 795-798
4. Kazerounian S., Yee K.O., and Lawler J. Thrombospondins in cancer. Cell Mol Life Sci 65 (2008) 700-712
5. Zhang X., Xu J., Lawler J., Terwilliger E., and Parangi S. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin. Clin Cancer Res 13 (2007) 3968-3976
6. Yang Q., Tian Y., Liu S., Zeine R., Chlenski A., Salwen H.R., et al. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma. Cancer Res 67 (2007) 1716-1724
7. Zhang X., and Lawler J. Thrombospondin-based antiangiogenic therapy. Microvasc Res 74 (2007) 90-99
8. Yamauchi M., Imajoh-Ohmi S., and Shibuya M. Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle. Cancer Sci 98 (2007) 1491-1497
9. Oganesian A., Armstrong L.C., Migliorini M.M., Strickland D.K., and Bornstein P. Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells. Mol Biol Cell 19 (2008) 563-571
10. Greenaway J., Lawler J., Moorehead R., Bornstein P., Lamarre J., and Petrik J. Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol 210 (2007) 807-818
11. Chen Z.J., Le H.B., Zhang Y.K., Qian L.Y., and Li W.D. Microvessel density and expression of thrombospondin-1 in non-small cell lung cancer and their correlation with clinicopathological features. J Int Med Res 37 (2009) 551-556
12. de Fraipont F., El Atifi M., Gicquel C., Bertagna X., Chambaz E.M., and Feige J.J. Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations. J Clin Endocrinol Metab 85 (2000) 4734-4741
13. Karavasilis V., Malamou-Mitsi V., Briasoulis E., Tsanou E., Kitsou E., and Pavlidis N. Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma. Int J Gynecol Cancer 16 Suppl 1 (2006) 241-246
14. Gilabert-Estellés J., Ramón L.A., España F., Gilabert J., Vila V., Réganon E., et al. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems. Hum Reprod 22 (2007) 2120-2127
15. Tan X.J., Lang J.H., Liu D.Y., Shen K., Leng J.H., and Zhu L. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78 (2002) 148-153
16. Kitawaki J., Kado N., Ishihara H., Koshiba H., Kitaoka Y., and Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 83 (2003) 149-155
17. Vercellini P., Fedele L., Pietropaolo G., Frontino G., Somigliana E., and Crosignani P.G. Progestogens for endometriosis: forward to the past. Hum Reprod Update 9 (2003) 387-396
18. Ryan I.P., Schriock E.D., and Taylor R.N. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 78 (1994) 642-649
19. Girling J.E., and Rogers P.A. Recent advances in endometrial angiogenesis research. Angiogenesis 8 (2005) 89-99
20. Mirkin S., and Archer D.F. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, progesterone, and 17beta-estradiol on thrombospondin-1 mRNA in Ishikawa cells. Fertil Steril 82 (2004) 220-222
21. Sengupta K., Banerjee S., Saxena N.K., and Banerjee S.K. Thombospondin-1 disrupts estrogen-induced endothelial cell proliferation and migration and its expression is suppressed by estradiol. Mol Cancer Res 2 (2004) 150-158
22. Sarkar A.J., Chaturvedi K., Chen C.P., and Sarkar D.K. Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors. J Endocrinol 192 (2007) 395-403
23. Groothuis P.G., Nap A.W., Winterhager E., and Grümmer R. Vascular development in endometriosis. Angiogenesis 8 (2005) 147-156
24. Hyder S.M., Liang Y., and Wu J. Estrogen regulation of thrombospondin-1 in human breast cancer cells. Int J Cancer 125 (2009) 1045-1053
25. Girling J.E., Lederman F.L., Walter L.M., and Rogers P.A. Progesterone, but not estrogen, stimulates vessel maturation in the mouse endometrium. Endocrinology 148 (2007) 5433-5441
26. Mirkin S., and Archer D.F. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone. Contraception 70 (2004) 327-333
27. Iruela-Arispe M.L., Porter P., Bornstein P., and Sage E.H. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97 (1996) 403-412